Publications

Year: 2011

• Bakeera-Kitaka, S. (2011a). The HIV positive Male Adolescent,2nd Adolescent Health Workshop, A collaboration between Makerere University and Columbia University, Kampala, Makerere University and Columbia University. [More]
• Bakeera-Kitaka, S. (2011b). Good Clinical Practice and HIV/AIDS Research, Uganda National Academy of Sciences, Kampala, RAS meeting, Uganda National Academy of Sciences. [More]
• Hermans, S. M., Leth, F. V., Kiragga, A., Hoepelman, A. I., Lange, J. M. & Manabe, Y. C. (2011a). CD4+ T-cell Recovery after ART in HIV-TB Co-infected Patients is Blunted in Patients with ART-associated TB Compared to Patients with TB Treated Prior to ART., number p-149, Boston, Conference on Retroviruses and Opportunistic Infections, CROI. [More]
• Hermans, S., Castelnuovo, B., Kambugu, A., Lange, J., Hoepelman, A. & Manabe, Y. (2011b). Integration of HIV and TB services results in earlier and more prioritised ART initiation in Uganda, IAS conference on HIV pathogenesis,Treatment and Prevention, IAS Conference, IAS. [More]
• Nakanjako, D., Ssewanyana, I., Mayanja-Kizza, H., Kiragga, A., Colebunders, R., Manabe, Y. C. et al. (2011). High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort, Boston, CROI. [More]

Year: 2010

• Agnes, N., Christine, K., Muwonge, T., Andrew, K. & Sabrina, B.-. (2010). Perspectives in transition,” Knowledge, attitudes and practices of young people regarding HIV positive prevention in an urban HIV clinic in Uganda: A mixed methods study, XVIII IAC Vienna, XVIII IAC Vienna, Infectious Diseases Institute -Mulago Hospital. [More]
• Barbara, C., Joseph, S., Kiragga, A., Moses, K. & Yukari, M. (2010). Patients on ART in resource limited settings with episodes of intermediate viremia (1,001-10,000 copies/ml) are at risk of impaired immune-reconstitution and treatment failure, XVIII IAC Vienna, XVIII IAC Vienna, Infectious Diseases Institute -Mulago Hospital. [More]
• David, R. .., Tracy, L., David, B., Darin, W., Andrew, K., Edward, N. J. et al. (2010). mRNA Biomarkers of CD4 Immune Recovery with Antiretroviral Therapy in persons with AIDS in Sub-Saharan Africa, number 16-19, IDI, CROI 2010 San Francisco, Infectious Diseases Institute -Mulago Hospital. [More]
• Fred, S. (2010). Integrating Family Planning (FP) in HIV/AIDS Care Model: AIDC in Uganda, XVIII IAC Vienna, XVIII IAC Vienna, Infectious Diseases Institute -Mulago Hospital. [More]
• Fred, S., Carol, N., Ibrahim, L. & Andrew, K. (2010). Pregnancy Intention and Pregnancy Risk Behavior Among Women Receiving HIV/AIDS Care in Uganda, XVIII IAC Vienna, XVIII IAC Vienna, Infectious Diseases Institute -Mulago Hospital. [More]
• Hermans, S., Kiragga, A., Schaefer, P., Kambugu, A., Hoepelman, I. & Manabe, Y. (2010a). The use of efavirenz is associated with a decreased incidence of tuberculosis after antiretroviral therapy initiation in an urban HIV clinic in sub-Saharan Africa., Cape Town, International AIDS Society conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Hermans, S., Kiragga, A., Schaefer, P., Kambugu, A., Hoepelman, A. & Manabe, Y. (2010b). Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa., Sitges, Spain, 14th International Workshop on HIV Observational Databases, Infectious Diseases Institute -Mulago Hospital. [More]
• Jane, W., Danie, K., Prossy, K., Bonnie, W. & Andrew, K. (2010). Sexual behavior of HIV-positive persons before and after one year of Antiretroviral therapy at the Infectious Diseases Clinic, Kampala, Uganda., San Francisco, IDI, CROI. [More]
• Joseph, B. S., Yuka, M., Kiragga, A. & Castelnuovo, B. (2010). HIV patients on antiretroviral treatment diagnosed with smear positive tuberculosis and smear negative/extra-pulmonary have similar mortality rates, XVIII IAC Vienna, XVIII IAC Vienna, Infectious Diseases Institute -Mulago Hospital. [More]
• Kiragga, A., Castelnuovo, B., Kamya, M., Moore, R. & Manabe, C. Y. (2010). WHO Immunologic criteria are more predictive of treatment failure in patients from a Western Cohort compared to a cohort in Resource Limited Settings, Sitges, Spain, 14th International Workshop on HIV Observational Databases, Infectious Diseases Institute -Mulago Hospital. [More]
• Lamorde, M., Byakika-Kibwika, P., Kayom, V., Kalemeera, F., Flaherty, J., Boffito, M. et al. (2010a). Sub-optimal nevirapine concentrations during intrapartum compared with postpartum in HIV-1 infected Ugandan women, Sorrento -Italy, 11th International Workshop on Clinical Pharmacology of HIV, Infectious Diseases Institute -Mulago Hospital. [More]
• Lamorde, M., Byakika, P., Kiragga, A., Castelnuovo, B., Ncube, M., Babigumira, J. et al. (2010b). Medication refill adherence and viral rebound in a cohort of HIV-infected Ugandan adults in the 2nd year of antiretroviral therapy., Miami,USA, 5th International Conference of HIV Treatment Adherence (IAP, Infectious Diseases Institute -Mulago Hospital. [More]
• Lamorde, M., Byakika-Kibwika, P., Kayom, V., Kalemeera, F., Namakula, R., Boffito, M. et al. (2010c). Nevirapine plasma concentrations during initiation with 200 mg versus 400 mg daily in HIV/TB co-infected adults on rifampicin., number 16-19, IDI, CROI 2010 San Francisco, Infectious Diseases Institute -Mulago Hospital. [More]
• Nakiyingi, L., Ocama, P., Kateera, D., Asiimwe, B., Katabazi, F., Katamba, A. et al. (2010). Accuracy of an ‘In-house’ sputum polymerase chain reaction assay for rapid diagnosis of sputum smear negative pulmonary TB at Mulago hospital, Uganda, Miami Florida, USA,, 14th International Congress on Infectious Diseases (ICID), Infectious Diseases Institute -Mulago Hospital. [More]
• Petra, S., Barbara, C., Kathy, B., Sabine, H. & Yuka, M. (2010). Effect of the duration of antiretroviral therapy on the CD4 count at tuberculosis diagnosis in patients from a large urban clinic in Sub-Saharan Africa., Sitges,Spain, 15th International Workshop on HIV Observational Databases, Infectious Diseases Institute -Mulago Hospital. [More]
• Ponsiano, O., Barbara, C., Agnes, K., Steve, J. R., Moses, R. K., Robert, C. et al. (2010). Progressive normalization of liver enzyme elevation during the first 30 months of ART in an HIV positive patient cohort in Uganda, XVIII IAC Vienna, XVIII IAC Vienna, Infectious Diseases Institute -Mulago Hospital. [More]
• Robertson, G., Rasmussen, S., Hubbard, R., Newell, K., Denty, M. & Manabe, Y. (2010). Multi-media educational tool (speaking book) increases knowledge of clinical trials among HIV-positive patients in Kampala, Uganda, Uppsala, Research ethics and bioethics conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Sabine, M. H., Yukari, C. M., Andy, I. H. & Andrew, K. (2010). Increased Baseline CD4-count at ART Initiation Improves Survival and Leads to Decreased Incidence of Tuberculosis in an Urban HIV Clinic in Sub-Saharan Africa, CROI 2010 San Francisco, Infectious Diseases Institute -Mulago Hospital. [More]
• Wajja, A., Nabongo, P., Bakeera-Kitaka, S., Musoke, P. & Mayanja-Kizza, H. (2010). Sharing experiences and optimizing south-to-south collaboration in preparing resource limited sites for vaccine trials: The TB Vaccine sites, Arusha Tanzania, 5th European and Developing Countries Clinical Trials, Arusha Tanzania. [More]

Year: 2009

• Bakeera-Kitaka, S., Angevine, R., Dillingham, R. & Kekitiinwa, A. (2009). Barriers to ARV Therapy Adherence in a Cohort of Adolescents in Urban Uganda, Cape Town, International AIDS Society conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Birabwa, E., Matovu, E., Kihembo, C., Lutalo, I. & Kambugu, A. (2009). Sexually Transmitted Infection (STI) frequency and challenges of using family planning among discordant couples at AIDC, Cologne, Germany, 12th European AIDS Conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Boulware, D., Meya, D., Bergemann, T., Shuli, B., Kambugu, A., Janoff, E. et al. (2009). Serum Inflammatory Biomarkers Predict HIV Immune Reconstitution Inflammatory Syndrome and Death after Cryptococcal Meningitis, Montreal,Canada, 16th Conference on Retroviruses and Opportunistic infection, Infectious Diseases Institute -Mulago Hospital. [More]
• Castelnuovo, B., Kiragga, A., Kamya, M. & Manabe, Y. (2009a). Reasons for treatment change in a 3 year prospective cohort of patients started on first line antiretroviral treatment in Uganda, Lisbon, International Workshop on HIV Observational Databases, Infectious Diseases Institute -Mulago Hospital. [More]
• Castelnuovo, B., Kiragga, A., Kamya, M. & Manabe, Y. (2009b). Stavudine toxicity is the main reason for treatment change in women in a prospective cohort of patients started on first line antiretroviral treatment (ART) in Uganda, Cape Town, International AIDS Society conference, Infectious Diseases Institute -Mulago Hospital. [More]
• David, B. M., Barbara, C., Andrew, K., Yukari, C. M., Moses, K., Paul, B. et al. (2009a). Cost effectiveness of Serum Cryptococcal antigen (CRAG) screening to Prevent Death in HIV- infected persons with CD4, Cape Town, International AIDS Society conference, Infectious Diseases Institute -Mulago Hospital. [More]
• David, B., David, M., Tracy, ., Joshua, R., Darin, W., Darlisha, W. et al. (2009b). Gene expression biomarkers in blood predict cryptococcal immune reconstitution inflammatory syndrome, Cape Town, International AIDS Society conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Fred, S., Evelyn, N., Justine, W., Agnes, N. & Ibrahim, L. (2009). Predictors of Pregnancy Among HIV-Positive Women attending an Urban HIV-Care Center, Cape Town, International AIDS Society conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Hakim, S., Barbara, C., Agnes, K., Andrew, K., Moses, K., Philippa, E. et al. (2009). Factors associated with increasing HIV-1 resistance to antiretroviral therapy in an urban cohort in Kampala, Uganda, Cape Town, International AIDS Society conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Jane, W., Daniel, K., Prossy, K., Bonnie, W. & Andrew, K. (2009). Sexual behavior of HIV-positive persons before and after one year of Antiretroviral therapy at the Infectious Diseases Clinic, Kampala, Uganda., Chicago, IAPAC -International Association of Physicians in AIDS Care, Infectious Diseases Institute -Mulago Hospital. [More]
• Katabira, C., Castelnuovo, B., Bhushan, A., Lee, E., Kambugu, A. & Manabe, Y. (2009). Examining drug default for treatment of tuberculosis in an urban HIV clinic in Uganda, Windhoek, Namibia, 2009 HIV/AIDS Implementers meeting, Infectious Diseases Institute -Mulago Hospital. [More]
• Kiragga, A., Castelnuovo, B., Mambule, I., Kambugu, A. & Manabe, Y. (2009). Clinical and immunological outcomes of second line treatment delivered in a routine clinical setting in Uganda, Cape Town, International AIDS Society conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Kiragga, A., Castelnuovo, B., Nakanjako, D. & Manabe, Y. (2009). Risk Factors for Severe Anemia after Initiation of ART in Urban Uganda, Montreal,Canada, 16th Conference on Retroviruses and Opportunistic infection, Infectious Diseases Institute -Mulago Hospital. [More]
• Kiragga, A., Schaefer, P., Kambugu, A. & Castelnuovo, B. (2009). High rate of misclassification of treatment failure based on WHO immunological criteria in resource limited settings (Uganda), Cape Town, International AIDS Society conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Lamorde, M., P Byakika-Kibwika, P., Okaba, V., Kalemeera, F., Ryan, M., Hughes, C. et al. (2009a). Clinical pharmacology for Global Health, a North – South – South partnership., Arusha Tanzania, 5thEuropean and Developing Countries Clinical TrialsPartner, Infectious Diseases Institute -Mulago Hospital. [More]
• Lamorde, M., Waako, P., Tabuti, J., Obua, C., Lanyero, H., Kukunda, C. et al. (2009b). Traditional medicine use in the context of antiretroviral therapy in Uganda., Cologne, Germany, 12th European AIDS Conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Martin, J., Laker, M., Clutter, D., Kambugu, A., Orem, J., Janka, D. et al. (2009). Kaposi’s Sarcoma-Associated Immune Reconstitution Inflammatory Syndrome (KS-IRIS) In Africa: Initial Findings From A Prospective Evaluation (oral presentation), Montreal,Canada, 16th Conference on Retroviruses and Opportunistic infection, Infectious Diseases Institute -Mulago Hospital. [More]
• Matovu, E., Birabwa, E., Muwonge, T., Lutalo, I. & Kambugu, A. (2009). Sexually Transmitted Infection (STI) symptom prevalence, knowledge, disclosure and treatment seeking behaviours amongst discordant couples at the Infectious Diseases Institute, Cape Town, International AIDS Society conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Merry, C., Lamorde, M., Byakika-Kibwika, P., Kalemeera, F., Ryan, M., Hughes, C. et al. (2009). Irish post-graduate training supports a multi-disciplinary health team in Africa to confront HIV/AIDS, tuberculosis and malaria, Dublin,Ireland, 4th Level Conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Musiime, V., Ferrier, A., Bakeera – Kitaka, S., Odongo, F., Kekitiinwa, A., Thomason, M. et al. (2009). Pharmacokinetics of Once versus Twice Daily Lamivudine and Abacavir in HIV-1 Infected Ugandan Children in the ARROW trial, Cape Town, International AIDS Society conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Muwonge, T., Bakeera-Kitaka, S., Nkuraija, J., Lutalo, I. & Matovu, E. (2009). Sexually Transmitted Infections and family Planning usage among Young Adults accessing care at Infectious Diseases Institute (IDI), Mulago Kampala, Uganda, Cape Town, International AIDS Society conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Nakanjako, D., Mayanja-Kizza, H., Ouma, J., Wanyenze, R., Mwesigire, D., Namale, A. et al. (2009). Integrating Tuberculosis (TB) Screening And HIV/AIDS Care Improves Diagnosis Of TB-HIV Co-infections At An Urban Public HIV Clinic In Uganda, Cologne, Germany, 12th European AIDS Conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Nakanjako, D., Kiragga, A., Castelnuovo, B., Kambugu, A. & Munabe, Y. (2009). Initiating Antiretroviral Therapy at CD4 Counts Below 350 cells/ µl. What Does This Mean To HIV/AIDS Care Programs In Uganda?, Cologne, Germany, 12th European AIDS Conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Ocama, P., Castelnuovo, B., Kamya, M., Kirk, G., Reynolds, S., Kiragga, A. et al. (2009). Low incidence of liver enzyme elevation in HIV infected patients attending a large Urban treatment Center in Kampala, Uganda, Washington DC, USA, International Symposium on Viral Hepatitis and Liver Disease, Infectious Diseases Institute -Mulago Hospital. [More]
• Philippa, E., Fowzia, I., Agnes, K., Barbara, C., Andrew, K. & Moses, K. (2009). More advanced disease at ART initiation and high death rate from OIs explain higher mortality among African patients initiating antiretroviral therapy (ART) in Uganda compared to London, Montreal,Canada, 16th Conference on Retroviruses and Opportunistic infection, Infectious Diseases Institute -Mulago Hospital. [More]
• Robertson, G., Bruyn, G. D., Newell, K., A, K., McIntyre, J. & Gray, G. (2009a). Reliability of Reporting of Recent Sexual Activity within Couples, Cape Town, International AIDS Society conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Robertson, G., Bruyn, G. D., Newell, K., Menten, J., Kiragga, A., McIntyre, J. et al. (2009b). Health Control Beliefs, Risk Behaviour and HIV-serostatus in Soweto, South Africa, Cape Town, International AIDS Society conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Semitala, F., Kiragga, A., Castelnuovo, B., Kambugu, A., Kalyesubula, R., Mayanja- Kizza, H. et al. (2009). Toxicity to fixed dose stavudine, lamivudine and nevirapine in Uganda is very high but not associated with increased virologic failure, Cape Town, International AIDS Society conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Sewankambo, F., Nalugwa, C., Lutalo, I. & Kambugu, A. (2009). Factors associated with pregnancy intentions among women receiving HIV/AIDS Care in Uganda, Cologne, Germany, 12th European AIDS Conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Sewankambo, F., Nalugwa, C., Namale, G., Lutalo, I. & Kambugu, A. (2009). Determinants of contraceptive use among HIV infected women attend care in an urban center, Cologne, Germany, International AIDS Society conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Wandera, B., Sethi, A., Kiragga, A., Castelnuovo, B., Kambugu, A. & Kamya, M. (2009a). Resumption of sexual activity after initiation of antiretroviral therapy among previously abstinent individuals in Kampala, Uganda, Cologne,Germany, 12th European AIDS Conference, Infectious Diseases Institute -Mulago Hospital. [More]
• Wandera, B., Sethi, A., Easterbrook, P., Castelnuovo, B., Kiragga, A., Whalen, C. et al. (2009b). Clinical and immunological outcomes of second line treatment delivered in a routine clinical setting in Uganda, Cape Town, International AIDS Society conference, Infectious Diseases Institute -Mulago Hospital. [More]

Year: 2008

• Babigumira, J., Castelnuovo, B., Lamorde, M., Obuku, A. E., Kiragga, A., Schaefer, P. et al. (2008). The Cost-Effectiveness of a Pharmacy-Only Refill Program in a Large Urban HIV/AIDS Clinic in Kampala, Uganda, Observational Cohort Meeting 2008 in Malaga. [More]
• Boulware, D., Meya, D., Bergemann, T., Vlasova, I., Kambugu, A., McAdam, K. et al. (2008a). Biomarkers of Immune Activation Are Predictors of HIV Immune Reconstitution Inflammatory Syndrome, number 1007, In 15th Conference on Retroviruses and Opportunistic Infections 3rd – 6th February 2008, Boston, USA. [More]
• Boulware, D., Bergemann, T., Meya, D., Vlasova, I., Okiring, E., Kambugu, A. et al. (2008b). Microarray-based analysis of immune activation in AIDS patients in Sub-Saharan Africa before and after initiation of antiretroviral therapy, number WEPE0206, In AIDS 2008 - XVII International AIDS Conference 3rd – 8th August 2008, Mexico City. [More]
• Coutinho, A., Mermin, J., Ekwaru, J., Were, W., Bunnell, R., Kaharuza, F. et al. (2008). Utility of Routine Viral Load, CD4 Cell Count, and Clinical Monitoring among HIV-infected Adults in Uganda: A Randomized Trial, number 125, In 15th Conference on Retroviruses and Opportunistic Infections 3rd – 6th February 2008, Boston, USA. [More]
• Ibrahim, F., Kiragga, A., Castelnuovo, B., Kamya, M. & Easterbrook, P. (2008). High Rates of Opportunistic Infections (OIs) and Mortality During First Two Years of ART in Uganda Compared to African Patients in London, Observational Cohort Meeting 2008 in Malaga. [More]
• Jacob, S., Moore, C., Banura, P., Pinkerton, R., Meya, D., Opendi, P. et al. (2008). Severe sepsis in two Ugandan hospitals: a prospective study evaluating the management and outcomes of a predominantly HIV-1 infected population, number WEPE0133, In AIDS 2008 - XVII International AIDS Conference 3rd – 8th August 2008, Mexico City. [More]
• Kambugu, A., Castelnuovo, B., Kiragga, A., Kigonya, K., Kamya, M. & Easterbrook, P. (2008). Cause-specific Mortality and Contribution of Immune Reconstitution Inflammatory Syndrome during the First 2 Years of ART in Uganda, number 845, In 15th Conference on Retroviruses and Opportunistic Infections 3rd – 6th February 2008, Boston, USA. [More]
• Kiragga, A., Ocama, P., Reynolds, S., Ojiambo, H., Kambugu, A. & Castelnuovo, B. (2008a). Lactate Measurement of Patients with Suspected Lactic Acidosis with a Hand-held Analyzer in a Large Outpatient HIV Clinic in Kampala, Uganda, number 992, In 15th Conference on Retroviruses and Opportunistic Infections 3rd – 6th February 2008, Boston, USA. [More]
• Kiragga, A., Castelnuovo, B., Kambugu, A., Schaefer, P., Kamya, M. & Easterbrook, P. (2008b). Validation of the quality of data collection in a large observational clinic database in Uganda using a nested research cohort., Observational Cohort Meeting 2008 in Malaga. [More]
• Kiragga, A., Castelnuovo, B., Munabe, Y. & Kambugu, A. (2008). Initiating Antiretroviral Therapy at CD4 Counts below 350 cells/ µl. What Does This Mean To HIV/AIDS Care Programs In Uganda?, 48th Annual ICAAC/IDSA 46th Annual Meeting 25th – 28th October 2008, Washington, DC. [More]
• Muwanga, A., Easterbrook, P., Schaefer, P., Wandera, M., Okello, D., Castelnuovo, B. et al. (2008). Losses to Follow-up in a Large ART Program in Uganda, number 840, In 15th Conference on Retroviruses and Opportunistic Infections 3rd – 6th February 2008, Boston, USA. [More]
• Nakanjako, D., Kiragga, A., Ibrahim, F., Castelnouvo, B., Kamya, M. R. & Easterbrook, P. (2008). Clinical Significance of Sub-Optimal CD4 Reconstitution Despite Viral Suppression in an Urban Cohort Initiating Antiretroviral Therapy in Sub-Saharan Africa., Observational Cohort Meeting 2008 in Malaga. [More]
• O'reilly, J., Ocama, P., Opio, K., Andama, A. & Sofair, A. (2008). Hepatitis C seroprevalence among HIV-positive and HIV-negative patients in Kampala, Uganda, number WEPE0184, In AIDS 2008 - XVII International AIDS Conference 3rd – 8th August 2008, Mexico City. [More]
• Opwonya, M. L., Kambugu, A., Kiirya, M., Phillips, A., Janka, D., Orem, J. et al. (2008). Removing the obstacles towards timely diagnosis of Kaposi’s sarcoma in Sub-Saharan Africa: use of simple equipment and easier patient access to hasten the performance of biopsies, number THPE0228, In AIDS 2008 - XVII International AIDS Conference 3rd – 8th August 2008, Mexico City. [More]
• Stabinski, L., Reynolds, S., Ocama, P., Serwadda, D., Quinn, T., Thomas, D. et al. (2008). On-going sexual transmission of HBV infection among the highly susceptible adult population of Rakai, Uganda, number MOPE0386, In AIDS 2008 - XVII International AIDS Conference 3rd – 8th August 2008, Mexico City. [More]